Robert Preissner
Charité - Universitätsmedizin Berlin
H-index: 56
Europe-Germany
Top articles of Robert Preissner
Cellular Mechanisms Underlying the Pathogenetic Role of the Primary Cilium in Pulmonary Arterial Hypertension
2024/5
Data-driven analysis of chemicals, proteins and pathways associated with peanut allergy: from molecular networking to biological interpretation
Food Science and Human Wellness
2024/5/1
Robert Preissner
H-Index: 31
Association of Herpes simplex infection with significantly increased risk of head and neck cancer: real‐world evidence of about 500,000 patients
International Journal of Dermatology
2024/4/21
Max Heiland
H-Index: 30
Robert Preissner
H-Index: 31
Non-animal models for blood–brain barrier permeability evaluation of drug-like compounds
Scientific Reports
2024/4/17
Robert Preissner
H-Index: 31
Exogenous Estrogen in the Development of Head and Neck Cancer
JAMA Otolaryngology–Head & Neck Surgery
2024/3/28
Beneficial Effect of Metformin on the Five-Year Survival in about 40,000 Patients with Head and Neck Cancer
Cancers
2024/2/28
Max Heiland
H-Index: 30
Robert Preissner
H-Index: 31
Withdrawn 2.0—update on withdrawn drugs with pharmacovigilance data
Nucleic Acids Research
2024/1/5
Robert Preissner
H-Index: 31
Real-world experience and clinical impact of drug-drug interactions in HR+/HER2-advanced breast cancer patients treated with abemaciclib plus endocrine therapy: the AB-ITALY study
2023/7/7
Using real-world evidence data and digital monitoring to analyze the hepatotoxic profiles of biologics across more than two million patients
Scientific Reports
2023/7/5
Robert Preissner
H-Index: 31
Statin Medication Improves Five-Year Survival Rates in Patients with Head and Neck Cancer: A Retrospective Case-Control Study of about 100,000 Patients
Cancers
2023/6/7
Max Heiland
H-Index: 30
Robert Preissner
H-Index: 31
Cystic fibrosis transmembrane conductance regulator potentiators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patients
2023/5/23
224P Clinical features and outcomes in HER2+ mBC patients treated with trastuzumab deruxtecan: A subgroup analysis of the De-REAL study
ESMO Open
2023/5/1
Antibiotics Significantly Decrease the Survival of Head and Neck Carcinoma Patients with Immunotherapy: A Real-World Analysis of More Than 3000 Cases
Cancers
2023/4/18
Betulin and its derivatives reduce inflammation and COX-2 activity in macrophages
Inflammation
2023/4
Robert Preissner
H-Index: 31
Real-world evidence for beneficial effects of dipyrone in 4,278 patients with pulmonary hypertension–Analysis of the risk of ventilation, hospitalization, and agranulocytosis
European Journal of Pharmacology
2023/3/15
Mehmet Akyüz
H-Index: 9
Robert Preissner
H-Index: 31
Increased incidence of adult-onset Still’s disease in association with COVID-19 vaccination and SARS-CoV-2 infection
Orphanet Journal of Rare Diseases
2023/3/10
Max Heiland
H-Index: 30
Robert Preissner
H-Index: 31
Abstract P1-11-13: DE-REAL: ITALIAN MULTICENTER EXPERIENCE OF TRASTUZUMAB DERUXTECAN IN A REAL WORLD SETTING
Cancer Research
2023/3/1
Sema7A and Sema4D Heterodimerization is Essential for Membrane Targeting and Neocortical Wiring
bioRxiv
2023/2/10
A retrospective case–control study for the comparison of 5-year survival rates: the role of adjuvant and neoadjuvant chemotherapy in craniofacial bone sarcoma in adults
Therapeutic Advances in Medical Oncology
2023/2
Robert Preissner
H-Index: 31
Max Heiland
H-Index: 30
The risk of osteomyelitis after mandibular fracture is doubled in men versus women: analysis of 300,000 patients
Scientific Reports
2023/11/27
Max Heiland
H-Index: 30
Robert Preissner
H-Index: 31
Co-Authors
